-transparent.png){kind=logo}
CA 125, CA 19.9 and CA 15.3 are antigenic determinants on glycoproteins commonly used as serum markers in gynecologic oncology. CA 125 was also investigated in the amniotic compartment of Down's syndrome pregnancies. The objective of this study was to evaluate the concentration of CA 19.9 and CA 15.3 in the amniotic fluid of normal and Down pregnancies. The concentration of these antigens was measured in stored amniotic fluid samples from 15-19 weeks pregnancies with and without Down's syndrome fetuses and expressed in multiples of the median for normal pregnancies of the same gestational age. The study group included 20 samples selected from single Down's syndrome pregnancies. Each of these samples were matched with three control samples from unaffected pregnancies, matched for maternal age, gestational age and duration of storage of the sample. The median MoM values of CA 19.9 and CA 15.3 in Down's syndrome pregnancies were respectively 1.11 MoM and 1.16 MoM, not significantly different from those of unaffected pregnancies (CA 19.9: 1.02 MoM; CA 15.3: 0.99 MoM). In the present study we have not found significantly different levels of CA 19.9 and CA 15.3 in the amniotic fluid of fetuses affected by Down's syndrome and in the controls.
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
September 1994,
European journal of obstetrics, gynecology, and reproductive biology,
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
January 1997,
The Journal of endocrinology,
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
January 1999,
International journal of fertility and women's medicine,
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
January 1998,
Duodecim; laaketieteellinen aikakauskirja,
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
January 1988,
Revue des maladies respiratoires,
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
March 1984,
Obstetrics and gynecology,
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
January 1990,
European journal of gynaecological oncology,
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
January 1988,
Anticancer research,
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
January 1999,
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
I Noci, and
P Borri, and
R Biagiotti, and
E Cariati, and
F Branconi, and
F Torricelli, and
G Cappelli, and
A D'Agata
January 1996,
Journal of the Society for Gynecologic Investigation,
